Aurinia Pharmaceuticals Share Price Today
(NASDAQ: AUPH)

Name: Aurinia Pharmaceuticals Share Price Today (NASDAQ: AUPH) - Aurinia Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Aurinia Pharmaceuticals share price is $7.75 & ₹662.35 as on 17 Apr 2025, 09.30 hrs IST

$7.75

▲

0.08

(1.04%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Aurinia Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Aurinia Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aurinia Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Aurinia Pharmaceuticals share price movements

Today's Low: $7.63
Today's High: $7.77
$7.75
1.55%
Downside
Day's Volatility :1.8%
Upside
0.26%
52 Weeks Low: $4.77
52 Weeks High: $10.67
$7.75
38.45%
Downside
52 Weeks Volatility :55.3%
Upside
27.37%

Aurinia Pharmaceuticals (AUPH) Returns

Period	Aurinia Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	0.26%	-3.3%	0.0%
6 Months	8.09%	-11.5%	0.0%
1 Year	55.31%	-2.5%	0.0%
3 Years	-29.22%	-2.1%	-12.9%

Aurinia Pharmaceuticals (AUPH) Key Statistics

in dollars & INR

Previous Close	$7.67
Open	$7.63
Today's High	$7.77
Today's Low	$7.63
Market Capitalization	$1.1B
Today's Volume	$929.3K
52 Week High	$10.67
52 Week Low	$4.77
Revenue TTM	$235.1M
EBITDA	$32.0M
Earnings Per Share (EPS)	$0.04
PE Ratio	193.75
Profit Margin	2.45%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	1.52%

How to invest in Aurinia Pharmaceuticals Stock (AUPH) from India?

It is very easy for Indian residents to invest directly in Aurinia Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aurinia Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aurinia Pharmaceuticals or AUPH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aurinia Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aurinia Pharmaceuticals shares which would translate to 0.110 fractional shares of Aurinia Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aurinia Pharmaceuticals, in just a few clicks!

Returns in Aurinia Pharmaceuticals (AUPH) for Indian investors in Rupees

The Aurinia Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Aurinia Pharmaceuticals investment value today

Current value as on today

₹1,57,652

Returns

₹57,652

(+57.65%)

Returns from Aurinia Pharmaceuticals Stock

₹55,311 (+55.31%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Aurinia Pharmaceuticals (AUPH)

200%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Aurinia Pharmaceuticals Stock from India on INDmoney has increased by 200% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Aurinia Pharmaceuticals

BlackRock Inc
6.52%
TANG CAPITAL MANAGEMENT LLC
6.14%
Armistice Capital, LLC
4.66%
NEA Management Company, LLC
2.89%
State Street Corp
2.12%
Geode Capital Management, LLC
1.28%

Analyst Recommendation on Aurinia Pharmaceuticals

Rating

Trend

Buy

84%Buy

15%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Aurinia Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Aurinia Pharmaceuticals Stock (AUPH)

What analysts predicted

Upside of 26.88%

Target:

$9.83

Current:

$7.75

Insights on Aurinia Pharmaceuticals Stock (Ticker Symbol: AUPH)

Price Movement
In the last 1 year, AUPH stock has moved up by 55.3%
Decreasing Revenue
Revenue is down for the last 2 quarters, 67.77M → 59.86M (in $), with an average decrease of 11.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 14.35M → 1.42M (in $), with an average decrease of 90.0% per quarter
AUPH vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 78.3% return, outperforming this stock by 23.0%
AUPH vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 30.5% return, outperforming this stock by 61.0%
Price to Sales
ForAUPH every $1 of sales, investors are willing to pay $4.7, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Aurinia Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Aurinia Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Aurinia Pharmaceuticals (AUPH) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aurinia Pharmaceuticals Inc	-6.85%	8.09%	55.31%	-29.22%	-53.0%
Regeneron Pharmaceuticals, Inc.	-15.01%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-12.04%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.13%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-7.49%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aurinia Pharmaceuticals Inc	193.75	193.75	0.0	0.47	0.02	0.01	NA	2.68
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aurinia Pharmaceuticals Inc	Buy	$1.1B	-53.0%	193.75	2.45%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Organization	Aurinia Pharmaceuticals
Employees	130
CEO	Mr. Peter S. Greenleaf M.B.A.
Industry	Health Technology

Management People of Aurinia Pharmaceuticals

Name	Title
Mr. Peter S. Greenleaf M.B.A.	CEO & Director
Mr. Joseph M. Miller CPA	Chief Financial Officer
Mr. Matthew Maxwell Donley M.B.A.	Chief Operations Officer
Dr. Premchandran Ramiya Ph.D.	Senior Vice President of Manufacturing & Supply Chain

Important FAQs about investing in AUPH Stock from India :

What is Aurinia Pharmaceuticals share price today?

Aurinia Pharmaceuticals share price today stands at $7.75, Open: $7.63 ; Previous Close: $7.67 ; High: $7.77 ; Low: $7.63 ; 52 Week High: $10.67 ; 52 Week Low: $4.77.

The stock opens at $7.63, after a previous close of $7.67. The stock reached a daily high of $7.77 and a low of $7.63, with a 52-week high of $10.67 and a 52-week low of $4.77.

Can Indians buy Aurinia Pharmaceuticals shares?

Yes, Indians can invest in the Aurinia Pharmaceuticals (AUPH) from India.

With INDmoney, you can buy Aurinia Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aurinia Pharmaceuticals at zero transaction cost.

How can I buy Aurinia Pharmaceuticals shares from India?

It is very easy to buy Aurinia Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aurinia Pharmaceuticals (AUPH) be purchased?

Yes, you can buy fractional shares of Aurinia Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Aurinia Pharmaceuticals stocks?

To start investing in Aurinia Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.